ATE90342T1 - 1-hydroxyvitamin d2-epimer und dessen derivate. - Google Patents

1-hydroxyvitamin d2-epimer und dessen derivate.

Info

Publication number
ATE90342T1
ATE90342T1 AT90104564T AT90104564T ATE90342T1 AT E90342 T1 ATE90342 T1 AT E90342T1 AT 90104564 T AT90104564 T AT 90104564T AT 90104564 T AT90104564 T AT 90104564T AT E90342 T1 ATE90342 T1 AT E90342T1
Authority
AT
Austria
Prior art keywords
vitamin
hydroxy
derivatives
hydroxyvitamin
epimer
Prior art date
Application number
AT90104564T
Other languages
English (en)
Inventor
Hector F Deluca
Heinrich K Schnoes
Kato L Perlman
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE90342T1 publication Critical patent/ATE90342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90104564T 1989-03-09 1990-03-09 1-hydroxyvitamin d2-epimer und dessen derivate. ATE90342T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/321,254 US4973584A (en) 1989-03-09 1989-03-09 Novel 1α-hydroxyvitamin D2 epimer and derivatives

Publications (1)

Publication Number Publication Date
ATE90342T1 true ATE90342T1 (de) 1993-06-15

Family

ID=23249837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90104564T ATE90342T1 (de) 1989-03-09 1990-03-09 1-hydroxyvitamin d2-epimer und dessen derivate.

Country Status (15)

Country Link
US (1) US4973584A (de)
EP (1) EP0386793B1 (de)
JP (1) JPH0737443B2 (de)
KR (1) KR950005776B1 (de)
AT (1) ATE90342T1 (de)
AU (1) AU631618B2 (de)
CA (1) CA1335105C (de)
DE (1) DE69001839T2 (de)
DK (1) DK0386793T3 (de)
ES (1) ES2055193T3 (de)
HU (1) HU207040B (de)
IL (1) IL93456A (de)
NZ (1) NZ232735A (de)
RU (1) RU2065851C1 (de)
WO (1) WO1990010619A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5756783A (en) * 1990-09-21 1998-05-26 Bone Care International, Inc. 1α-Hydroxy-24-EPI-vitamin D4
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US5789397A (en) * 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US5182396A (en) * 1991-03-29 1993-01-26 Nisshin Flour Milling Co., Ltd. 1-hydroxyvitamin d derivatives
IL104201A0 (en) * 1991-12-26 1993-05-13 Wisconsin Alumni Res Found 26,27-dimethylene-1 alpha-25-dihydroxyvitamin d2 and its 24-epimer and pharmaceutical compositions containing them
AU682817B2 (en) * 1992-01-29 1997-10-23 Bone Care International, Inc. 1alpha-hydroxy-24-(epi)-vitamin D4
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
CA2121689C (en) * 1992-08-28 2008-03-18 Ronald L. Horst 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use
TW267161B (de) * 1992-11-20 1996-01-01 Hoffmann La Roche
JPH0753384A (ja) * 1993-07-13 1995-02-28 Wisconsin Alumni Res Found ２４−エピ−１α−ヒドロキシビタミンＤ２ を含んでなる骨粗鬆症治療剤
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5373004A (en) * 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
AU1525700A (en) 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
CA2366586C (en) * 1999-04-01 2004-06-22 Johns Hopkins University Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1.alpha., 25-dihydroxy vitamin d3
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
WO2003018545A1 (en) * 2001-08-22 2003-03-06 Johns Hopkins University 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
US7101865B2 (en) 2002-06-13 2006-09-05 Cytochroma Inc. 24-sulfoximine vitamin D3 compounds
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
US7232810B2 (en) * 2003-08-20 2007-06-19 Wisconsin Alumni Research Foundation 2-methylene-19-nor-vitamin D2 compounds
EA201691980A1 (ru) 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンｄ３およびその類似体
JP6608810B2 (ja) 2013-05-29 2019-11-20 バーグ エルエルシー ビタミンｄを使用する化学療法誘発性脱毛症の予防又は軽減

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US3907843A (en) * 1974-06-14 1975-09-23 Wisconsin Alumni Res Found 1{60 -Hydroxyergocalciferol and processes for preparing same
NL193245C (nl) * 1983-05-09 1999-04-02 Wisconsin Alumni Res Found Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat.
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
US4717721A (en) * 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity

Also Published As

Publication number Publication date
AU631618B2 (en) 1992-12-03
ES2055193T3 (es) 1994-08-16
IL93456A (en) 1994-02-27
JPH03504508A (ja) 1991-10-03
WO1990010619A1 (en) 1990-09-20
AU5192590A (en) 1990-10-09
KR950005776B1 (ko) 1995-05-30
KR920700201A (ko) 1992-02-19
DK0386793T3 (da) 1993-08-02
JPH0737443B2 (ja) 1995-04-26
EP0386793B1 (de) 1993-06-09
RU2065851C1 (ru) 1996-08-27
US4973584A (en) 1990-11-27
EP0386793A1 (de) 1990-09-12
NZ232735A (en) 1992-07-28
DE69001839T2 (de) 1993-09-16
HU207040B (en) 1993-03-01
CA1335105C (en) 1995-04-04
DE69001839D1 (de) 1993-07-15
HU902288D0 (en) 1991-07-29
IL93456A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
ATE90342T1 (de) 1-hydroxyvitamin d2-epimer und dessen derivate.
DE69006052D1 (de) 19-Nor-Vitamin-D-Derivate.
ATE69376T1 (de) Haarwuchsmittel.
ES515032A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
ZW22687A1 (en) Treatment of diseases caused by viruses
IL95813A0 (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ATE70069T1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
MX163341A (es) N procedimiento para la preparacion de nuevas 1,4 dihidropiridinas,utiles como medicamentos antibioticos
EP0245669A3 (en) Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT1184611B (it) Dispositivo per la produzione di aria sterile
ES2094757T3 (es) Un factor megacariocitopoyetico.
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
IT1213100B (it) La produzione di prodotti sessuali impiego di sostanze stimolanti per da mammiferi,adatti per la fecondazione naturale ed artificiale e sostanze relative
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
FI944907A0 (fi) Uusi antineoplastinen sytokiini
MC2152A1 (fr) Procede de preparation du 10,10-dioxyde de 1-ethylphenoxathiine et ce compose ainsi prepare
FR2637465B1 (fr) Procede de conservation, notamment d'algues fraiches
AR240063A1 (es) Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135.
IT8041526A0 (it) Preparazione biologica per la stimolazione dell'attivita' vitale di organismi biologici eprocedimento per la produzione della stessa.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee